قالب وردپرس درنا توس
Home / Science / Coronavirus: Israeli-made nasal spray can reduce infection when people gather

Coronavirus: Israeli-made nasal spray can reduce infection when people gather



According to the latest preliminary research, during Rosh Hashanah in the highly popular Bnei Brak community, nasal sprays may reduce the rate of coronavirus infection.

About 83 members of an ultra-Orthodox synagogue in Bnei Brak used the nasal spray “Traffix” during the Jewish New Year service. Two weeks later, 2.4% of Traffix users were infected with the coronavirus and 10% of non-users Is infected with the coronavirus. Coronavirus.

The risk of coronavirus infection among Traffix users has been reduced by 78%.

As a result, the researchers suggested that Traffix should be used in addition to other preventive measures. No side effects have been reported among users.

The nasal spray manufactured by Nasus Pharma is a nasal powder inhaler that forms a protective layer on the nasal mucosa to prevent viruses from infecting nasal cells. The main ingredient in Traffix, hydroxypropyl methylcellulose, forms a mucosal glue covering the nasal cells, preventing the virus from binding to the receptor.

It also creates an acidic microenvironment that can be maintained for five hours and has been proven to prevent respiratory diseases such as N1
H1 influenza and rhinovirus. The spray has been approved for use in Europe and Israel.

Nasus Pharma is a biopharmaceutical company based in Tel Aviv dedicated to the development of intranasal powder products designed to treat patients in acute and emergency situations. The company focuses on nasal products because they have higher dispersibility and faster nasal absorption.

The research was done by researchers from Haifa University, University of Virginia, Nasus Pharma and Hadassah Medical Center. This is preliminary and has not yet been peer reviewed.




Source link